These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 24842301)
1. Integrated analysis using methylation and gene expression microarrays reveals PDE4C as a prognostic biomarker in human glioma. Bao Z; Feng Y; Wang H; Zhang C; Sun L; Yan Z; Liu Q; Guo T; Li M; Yang X; Jiang C; Zhang Q; Jiang T Oncol Rep; 2014 Jul; 32(1):250-60. PubMed ID: 24842301 [TBL] [Abstract][Full Text] [Related]
2. Methylation Status of the RIZ1 Gene Promoter in Human Glioma Tissues and Cell Lines. Zhang C; Meng W; Wang J; Lu Y; Hu G; Hu L; Ma J Cell Mol Neurobiol; 2017 Aug; 37(6):1021-1027. PubMed ID: 27757741 [TBL] [Abstract][Full Text] [Related]
3. P-cadherin overexpression is an indicator of clinical outcome in invasive breast carcinomas and is associated with CDH3 promoter hypomethylation. Paredes J; Albergaria A; Oliveira JT; Jerónimo C; Milanezi F; Schmitt FC Clin Cancer Res; 2005 Aug; 11(16):5869-77. PubMed ID: 16115928 [TBL] [Abstract][Full Text] [Related]
4. Promoter hypermethylation-mediated inactivation of LRRC4 in gliomas. Zhang Z; Li D; Wu M; Xiang B; Wang L; Zhou M; Chen P; Li X; Shen S; Li G BMC Mol Biol; 2008 Nov; 9():99. PubMed ID: 18976507 [TBL] [Abstract][Full Text] [Related]
5. Downregulation of HTATIP2 expression is associated with promoter methylation and poor prognosis in glioma. Dong X; Deng Q; Nie X; Zhang M; Jia W; Chen C; Xu C; Xu R Exp Mol Pathol; 2015 Apr; 98(2):192-9. PubMed ID: 25617528 [TBL] [Abstract][Full Text] [Related]
6. 5-Aza-2'-deoxycytidine induces retinoic acid receptor-beta(2) demethylation and growth inhibition in esophageal squamous carcinoma cells. Liu Z; Zhang L; Ding F; Li J; Guo M; Li W; Wang Y; Yu Z; Zhan Q; Wu M; Liu Z Cancer Lett; 2005 Dec; 230(2):271-83. PubMed ID: 16297713 [TBL] [Abstract][Full Text] [Related]
7. Genome-wide analysis of epigenetic silencing identifies BEX1 and BEX2 as candidate tumor suppressor genes in malignant glioma. Foltz G; Ryu GY; Yoon JG; Nelson T; Fahey J; Frakes A; Lee H; Field L; Zander K; Sibenaller Z; Ryken TC; Vibhakar R; Hood L; Madan A Cancer Res; 2006 Jul; 66(13):6665-74. PubMed ID: 16818640 [TBL] [Abstract][Full Text] [Related]
8. Methylation-associated silencing of death-associated protein kinase gene in laryngeal squamous cell cancer. Kong WJ; Zhang S; Guo C; Zhang S; Wang Y; Zhang D Laryngoscope; 2005 Aug; 115(8):1395-401. PubMed ID: 16094112 [TBL] [Abstract][Full Text] [Related]
9. Hypermethylation-modulated down-regulation of CDH1 expression contributes to the progression of esophageal cancer. Ling ZQ; Li P; Ge MH; Zhao X; Hu FJ; Fang XH; Dong ZM; Mao WM Int J Mol Med; 2011 May; 27(5):625-35. PubMed ID: 21373750 [TBL] [Abstract][Full Text] [Related]
10. Identification of the A kinase anchor protein 12 (AKAP12) gene as a candidate tumor suppressor of hepatocellular carcinoma. Hayashi M; Nomoto S; Kanda M; Okamura Y; Nishikawa Y; Yamada S; Fujii T; Sugimoto H; Takeda S; Kodera Y J Surg Oncol; 2012 Mar; 105(4):381-6. PubMed ID: 22052684 [TBL] [Abstract][Full Text] [Related]
11. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers. Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA 345, a methylation-sensitive microRNA is involved in cell proliferation and invasion in human colorectal cancer. Tang JT; Wang JL; Du W; Hong J; Zhao SL; Wang YC; Xiong H; Chen HM; Fang JY Carcinogenesis; 2011 Aug; 32(8):1207-15. PubMed ID: 21665895 [TBL] [Abstract][Full Text] [Related]
13. Epigenetic silencing of death receptor 4 mediates tumor necrosis factor-related apoptosis-inducing ligand resistance in gliomas. Elias A; Siegelin MD; Steinmüller A; von Deimling A; Lass U; Korn B; Mueller W Clin Cancer Res; 2009 Sep; 15(17):5457-65. PubMed ID: 19706813 [TBL] [Abstract][Full Text] [Related]
14. Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer. Veeck J; Noetzel E; Bektas N; Jost E; Hartmann A; Knüchel R; Dahl E Mol Cancer; 2008 Nov; 7():83. PubMed ID: 18990230 [TBL] [Abstract][Full Text] [Related]
15. TP53 promoter methylation in human gliomas. Amatya VJ; Naumann U; Weller M; Ohgaki H Acta Neuropathol; 2005 Aug; 110(2):178-84. PubMed ID: 16025287 [TBL] [Abstract][Full Text] [Related]
16. Frequent epigenetic inactivation of the SLIT2 gene in gliomas. Dallol A; Krex D; Hesson L; Eng C; Maher ER; Latif F Oncogene; 2003 Jul; 22(29):4611-6. PubMed ID: 12881718 [TBL] [Abstract][Full Text] [Related]
17. Aberrant methylation of RASSF2A in human pancreatic ductal adenocarcinoma and its relation to clinicopathologic features. Zhao L; Cui Q; Lu Z; Chen J Pancreas; 2012 Mar; 41(2):206-11. PubMed ID: 21792082 [TBL] [Abstract][Full Text] [Related]
18. Epigenomic profiling reveals novel and frequent targets of aberrant DNA methylation-mediated silencing in malignant glioma. Kim TY; Zhong S; Fields CR; Kim JH; Robertson KD Cancer Res; 2006 Aug; 66(15):7490-501. PubMed ID: 16885346 [TBL] [Abstract][Full Text] [Related]
19. Molecular genetic and epigenetic analysis of NCX2/SLC8A2 at 19q13.3 in human gliomas. Qu M; Jiao H; Zhao J; Ren ZP; Smits A; Kere J; Nistér M Neuropathol Appl Neurobiol; 2010 Apr; 36(3):198-210. PubMed ID: 20132488 [TBL] [Abstract][Full Text] [Related]
20. [The methylation and mRNA expression of SLC5A8 and TMS1/ASC genes in human glioma]. Jiang Z; Li XG; Hu J; Lu DR; Zhou W; Jiang YQ; Li CY Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(5):292-7. PubMed ID: 17456354 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]